LyondellBasell: An Updated View On The Valuation Based On The Most Recent Result (Rating Downgrade)

LyondellBasell is viewed as unattractive after a significant dividend cut and a lower valuation assessment. The article argues that recent EBITDA growth in key segments is being driven by unsustainable geopolitical factors rather than fundamental improvement, while the technology segment's unpredictable earnings and high debt raise additional risk in a volatile rate environment. The overall message is bearish on the company's fundamentals and capital-return profile.

Analysis

The market is likely still underestimating how quickly a dividend reset can re-rate a stock from an income proxy to a cyclical balance-sheet story. Once capital return credibility breaks, the shareholder base shifts from yield buyers to event-driven and distressed screens, which usually compresses the multiple further than the dividend math alone implies. In that transition, the stock can trade less on near-term EBITDA and more on refinancing capacity, covenant headroom, and whether management is forced into asset sales or more aggressive working-capital release.

The bigger second-order effect is that any EBITDA strength driven by geopolitical distortions is a mirage for competitors: it can delay capacity rationalization elsewhere, keep product spreads noisy, and encourage peers to hold supply too long in hopes of a normalizing window. That sets up a later-cycle overshoot where margins mean-revert faster than consensus expects once shipping, energy, or regional arbitrage pressures fade. If rates stay volatile, the equity could de-rate even without an earnings miss because leveraged industrials are increasingly being priced like spread products rather than operating companies.

The key catalyst path is not a single quarter, but a sequence over the next 1-3 quarters: weaker guidance, higher funding costs, and no clear evidence the special geopolitical tailwind is persisting. A reversal would require either a credible deleveraging plan or a sustained improvement in free cash flow quality, not just a headline EBITDA print. Absent that, rallies should be treated as bear-market bounces rather than durable bottoms.

Contrarianly, the market may be focusing too much on the dividend cut itself and too little on the possibility that management is preemptively de-risking before a worse credit event. If so, the downside from here could be somewhat less linear than a pure yield-collapse chart suggests. But that still doesn’t justify owning it: the best-case scenario is stabilization, while the base case remains multiple compression until the balance sheet proves it can absorb a normalization in operating conditions.

Key Decisions for Investors

• Avoid initiating long exposure for the next 1-2 quarters; the risk/reward is asymmetrically negative because any rebound is likely to be sold into by former income holders and de-leveraging pressure remains the dominant narrative.
• If a tradable bounce emerges on a strong quarter, consider shorting into strength with a 1-3 month horizon; target is multiple compression rather than earnings collapse, with the trade working even on merely mediocre guidance.
• Prefer a pair trade: short leveraged chemical/industrial names with fragile capital returns against a less levered, higher-quality peer basket in the sector; the thesis is that balance-sheet quality will be rewarded over headline EBITDA.
• For event-driven traders, buy downside protection rather than outright shorting if borrow is tight: 3-6 month put spreads can express the view that the market will reprice refinance risk without requiring a catastrophic operating miss.
• Watch for any asset-sale or refinancing announcement as the key reversal trigger; if management demonstrates credible deleveraging, trim bearish exposure quickly because that would be the first signal the equity is transitioning from value trap to repair story.